NO20002189D0 - Use of macrolides for the treatment of cancer and mucous degeneration - Google Patents

Use of macrolides for the treatment of cancer and mucous degeneration

Info

Publication number
NO20002189D0
NO20002189D0 NO20002189A NO20002189A NO20002189D0 NO 20002189 D0 NO20002189 D0 NO 20002189D0 NO 20002189 A NO20002189 A NO 20002189A NO 20002189 A NO20002189 A NO 20002189A NO 20002189 D0 NO20002189 D0 NO 20002189D0
Authority
NO
Norway
Prior art keywords
macrolides
mucous
degeneration
cancer
treatment
Prior art date
Application number
NO20002189A
Other languages
Norwegian (no)
Other versions
NO20002189L (en
Inventor
Yat Sun Or
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20002189D0 publication Critical patent/NO20002189D0/en
Publication of NO20002189L publication Critical patent/NO20002189L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20002189A 1997-10-31 2000-04-27 Use of macrolides for the treatment of cancer and mucous degeneration NO20002189L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (en) 1997-10-31 1998-10-30 Use of macrolides for the treatment of cancer and macular degeneration

Publications (2)

Publication Number Publication Date
NO20002189D0 true NO20002189D0 (en) 2000-04-27
NO20002189L NO20002189L (en) 2000-06-28

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002189A NO20002189L (en) 1997-10-31 2000-04-27 Use of macrolides for the treatment of cancer and mucous degeneration

Country Status (17)

Country Link
EP (1) EP1027060A2 (en)
JP (1) JP2001521891A (en)
KR (1) KR20010031577A (en)
CN (1) CN1278178A (en)
AR (1) AR043071A1 (en)
AU (1) AU1206799A (en)
BG (1) BG104436A (en)
BR (1) BR9813318A (en)
CA (1) CA2307850A1 (en)
HU (1) HUP0100012A3 (en)
IL (1) IL135518A0 (en)
NO (1) NO20002189L (en)
PL (1) PL340604A1 (en)
SK (1) SK6172000A3 (en)
TR (1) TR200001147T2 (en)
WO (1) WO1999022722A2 (en)
ZA (1) ZA989885B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001248588B2 (en) 2000-04-13 2006-02-02 Biotica Technology Limited Hybrid glycosylated products and their production and use
ES2428354T3 (en) 2002-09-18 2013-11-07 Trustees Of The University Of Pennsylvania Rapamycin for use in the inhibition or prevention of choroidal neovascularization
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
CA2520377A1 (en) 2003-03-28 2004-10-14 Cornell Research Foundation, Inc. Migrastatin analog compositions and uses thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
CN1950388A (en) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 Macrocyclic compounds and methods of making and using the same
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
WO2006001967A2 (en) 2004-05-25 2006-01-05 Sloan-Kettering Institute For Cancer Research Migrastatin analogs in the treatment of cancer
CA2582766C (en) 2004-09-23 2014-07-22 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
DK1848431T3 (en) 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
US8470985B2 (en) 2005-08-24 2013-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
DK1934238T3 (en) 2005-08-24 2017-09-18 Melinta Therapeutics Inc TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE
AU2007212271B2 (en) 2006-02-09 2012-11-01 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
BRPI0709016A2 (en) 2006-03-23 2011-06-21 Macusight Inc formulations and methods for diseases or conditions related to vascular permeability
CN106317146B (en) * 2015-06-18 2019-06-21 沈阳药科大学 Bicyclic clarithomycin derivative and its as tumour cell increment inhibitor purposes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
BR9813318A (en) 2000-08-22
SK6172000A3 (en) 2001-03-12
BG104436A (en) 2000-12-29
HUP0100012A3 (en) 2003-07-28
PL340604A1 (en) 2001-02-12
JP2001521891A (en) 2001-11-13
TR200001147T2 (en) 2000-08-21
NO20002189L (en) 2000-06-28
AR043071A1 (en) 2005-07-20
CA2307850A1 (en) 1999-05-14
ZA989885B (en) 1999-05-05
KR20010031577A (en) 2001-04-16
EP1027060A2 (en) 2000-08-16
HUP0100012A2 (en) 2001-05-28
AU1206799A (en) 1999-05-24
WO1999022722A2 (en) 1999-05-14
IL135518A0 (en) 2001-05-20
CN1278178A (en) 2000-12-27
WO1999022722A3 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
NO991700D0 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
NO20002189L (en) Use of macrolides for the treatment of cancer and mucous degeneration
NO971015L (en) Compounds and Methods for the Treatment of Cancer
NO20004098L (en) Methods and preparations for the treatment of macrophage-mediated disorders
GB9903841D0 (en) Diagnosis and treatment of cancer
NO994778L (en) Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome
NO991701D0 (en) HIV and cancer treatment
DE69836008D1 (en) COMPOSITION AND TREATMENT AGENT
NO20015516D0 (en) Preparations and uses of ET743 for the treatment of cancer
NO991192D0 (en) Means for the treatment of prostate hypertrophy and prostate cancer
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
DE69836209D1 (en) PREVENTION AND TREATMENT OF HEPATOCELLULAR CANCER
NO20003229L (en) Combination of benzocycloheptapyridine compounds and antineoplastic agents for the treatment of proliferative diseases
NO983512D0 (en) Means for the treatment and prevention of AIDS
IL127739A0 (en) Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
GB9811598D0 (en) Diagnosis and treatment of cancer
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
NO20001758D0 (en) Methods and compositions for the treatment of arthritis
EE200300057A (en) Ingredients for the prevention and treatment of cancer
NO985068D0 (en) Vaccines for the treatment of lymphoma and leukemia
IL149281A0 (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
DE69810678D1 (en) Grain and seed treatment